Form 4 for PCVX Vaxcyte, Inc.
Accepted 2022-06-28 00:00:00 ET · period of report 2022-06-24 · accession 0001209191-22-039646 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-06-28 | 2022-06-24 | PCVX | PICKERING GRANT | CEO, Dir | S - Sale | $21.01 | -747 | 694.5K | -0.1% | -$15.7K | |
| I | 2022-06-28 | 2022-06-28 | PCVX | PICKERING GRANT | CEO, Dir | S - Sale | $21.00 | -10.0K | 345.7K | -3% | -$210.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-06-24 | S | D | 747 | $21.01 | 694,456 | D By Children's Trusts | — | — | (F2) The price reported is a weighted-average price. The shares were sold at prices ranging from $21.00 to $21.05. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| 2 | Common | Common Stock | 2022-06-28 | S | D | 10,000 | $21.00 | 345,660 | I | — | — |